Publications

Oral Presentation Approval / Commercialization Care Hepatology

Use of glucagon-like peptide 1 receptor agonists in patients with MASLD in a real-world setting is associated with slower disease progression and lower all-cause mortality.

Use of glucagon-like peptide 1 receptor agonists in patients with MASLD in a real-world setting is associated with slower disease progression and lower all-cause mortality

Oral Presentation Approval / Commercialization Care Dermatology

Patient reported burden is associated with clinician-reported severity in alopecia areata: Real world insights from TARGET-DERM AA.

Patient reported burden is associated with clinician-reported severity in alopecia areata: Real world insights from TARGET-DERM AA

Care Oral Presentation R&D Dermatology

Use of advanced systemic therapy in adolescent patients with moderate to severe atopic dermatitis in the TARGET DERM Registry.

Use of advanced systemic therapy in adolescent patients with moderate to severe atopic dermatitis in the TARGET DERM Registry (Hawaii Derm)

Care Oral Presentation R&D Methods/Pharmacoepi

Current Trends in the Risk of Subsequent Fracture After Initial Fracture, and Post-fracture Treatment Among Commercially Insured Postmenopausal Women in the United States.

Current Trends in the Risk of Subsequent Fracture After Initial Fracture, and Post-Fracture Treatment Among Commercially Insured Postmenopausal Women in the United States (ACR)

Oral Presentation Approval / Commercialization Care Hepatology

Non-alcoholic Steatohepatitis Disease Progression in Participants from the United States TARGET-NASH Real World Longitudinal Observational Study.

Non-alcoholic Steatohepatitis Disease Progression in Participants from the United States TARGET-NASH Real World Longitudinal Observational Study

Total Publications

Oral Presentation

2024 · Oral Presentation · Oral Presentation · Hepatology

Use of glucagon-like peptide 1 receptor agonists in patients with MASLD in a real-world setting is associated with slower disease progression and lower all-cause mortality.

2024 · Oral Presentation · Oral Presentation · Dermatology

Patient reported burden is associated with clinician-reported severity in alopecia areata: Real world insights from TARGET-DERM AA.

2023 · Oral Presentation · Care · Dermatology

Use of advanced systemic therapy in adolescent patients with moderate to severe atopic dermatitis in the TARGET DERM Registry.

2023 · Oral Presentation · Care · Methods/Pharmacoepi

Current Trends in the Risk of Subsequent Fracture After Initial Fracture, and Post-fracture Treatment Among Commercially Insured Postmenopausal Women in the United States.

2023 · Oral Presentation · Oral Presentation · Hepatology

Non-alcoholic Steatohepatitis Disease Progression in Participants from the United States TARGET-NASH Real World Longitudinal Observational Study.

2023 · Oral Presentation · Oral Presentation · Methods/Pharmacoepi

HIV risk perception and PrEP adherence among South African women planning for pregnancy and participating in STI screening.

2023 · Oral Presentation · Care · Dermatology

Unmet Needs of Adolescents with Moderate to Severe Atopic Dermatitis in the TARGET-DERM Registry.

2022 · Oral Presentation · Oral Presentation · Methods/Pharmacoepi

HIV Incidence in Botswana Rural Communities With High Antiretroviral Treatment Coverage: Results From the Botswana Combination Prevention Project, 2013-2017.

2022 · Oral Presentation · Oral Presentation · Methods/Pharmacoepi

Health Impact and Cost-Effectiveness of HIV Testing, Linkage, and Early Antiretroviral Treatment in the Botswana Combination Prevention Project.

2021 · Oral Presentation · Oral Presentation · Methods/Pharmacoepi

Lipids testing trends before and after hospitalization for myocardial infarction among adults in the United States, 2008-2019.

2020 · Oral Presentation · Oral Presentation · Hepatology

Clinical Profile of Nonalcoholic Fatty Liver Disease in Adults with Type 2 Diabetes Mellitus.

2020 · Oral Presentation · Oral Presentation · Gastroenterology

Objective Disease Activity Assessment and Therapeutic Drug Monitoring is Lacking Prior to Biologic Therapy Changes in Routine Inflammatory Bowel Disease Clinical Practice: TARGET-IBD.

2020 · Oral Presentation · Approval / Commercialization · Hepatology

Weight Loss and Change in Alanine Aminotransferase (ALT) Among Patients with Nonalcoholic Fatty Liver Disease (NAFLD) Receiving Standard Care in Real World Clinical Practice: TARGET-NASH.

2019 · Oral Presentation · Oral Presentation · Hepatology

Publications

Use of glucagon-like peptide 1 receptor agonists in patients with MASLD in a real-world setting is associated with slower disease progression and lower all-cause mortality.

Patient reported burden is associated with clinician-reported severity in alopecia areata: Real world insights from TARGET-DERM AA.

Use of advanced systemic therapy in adolescent patients with moderate to severe atopic dermatitis in the TARGET DERM Registry.

Current Trends in the Risk of Subsequent Fracture After Initial Fracture, and Post-fracture Treatment Among Commercially Insured Postmenopausal Women in the United States.

Non-alcoholic Steatohepatitis Disease Progression in Participants from the United States TARGET-NASH Real World Longitudinal Observational Study.

Use of glucagon-like peptide 1 receptor agonists in patients with MASLD in a real-world setting is associated with slower disease progression and lower all-cause mortality.

Patient reported burden is associated with clinician-reported severity in alopecia areata: Real world insights from TARGET-DERM AA.

Use of advanced systemic therapy in adolescent patients with moderate to severe atopic dermatitis in the TARGET DERM Registry.

Current Trends in the Risk of Subsequent Fracture After Initial Fracture, and Post-fracture Treatment Among Commercially Insured Postmenopausal Women in the United States.

Non-alcoholic Steatohepatitis Disease Progression in Participants from the United States TARGET-NASH Real World Longitudinal Observational Study.

HIV risk perception and PrEP adherence among South African women planning for pregnancy and participating in STI screening.

Unmet Needs of Adolescents with Moderate to Severe Atopic Dermatitis in the TARGET-DERM Registry.

HIV Incidence in Botswana Rural Communities With High Antiretroviral Treatment Coverage: Results From the Botswana Combination Prevention Project, 2013-2017.

Health Impact and Cost-Effectiveness of HIV Testing, Linkage, and Early Antiretroviral Treatment in the Botswana Combination Prevention Project.

Lipids testing trends before and after hospitalization for myocardial infarction among adults in the United States, 2008-2019.

Clinical Profile of Nonalcoholic Fatty Liver Disease in Adults with Type 2 Diabetes Mellitus.

Objective Disease Activity Assessment and Therapeutic Drug Monitoring is Lacking Prior to Biologic Therapy Changes in Routine Inflammatory Bowel Disease Clinical Practice: TARGET-IBD.

Weight Loss and Change in Alanine Aminotransferase (ALT) Among Patients with Nonalcoholic Fatty Liver Disease (NAFLD) Receiving Standard Care in Real World Clinical Practice: TARGET-NASH.

Incidence of Achieving Weight Loss Goals in Usual Clinical Practice: Results for the TARGET-NASH Observational Cohort.

Lipid testing trends in the US before and after the release of the 2013 ACC/AHA cholesterol guidelines.

Real-world patterns of romiplostim treatment in adults with primary immune thrombocytopenia in the United States.

Patterns and Predictors of Initiation of Intravenous Bisphosphonates Among Patients with Multiple Myeloma in the United States.